The Second COVID-19 Shot Is a Rude Reawakening for Immune Cells
Side effects are just a sign that protection is kicking in as it should.
Related Articles
Jumbo task: 400 pills a day for elephants with TB at Karachi’s Safari Park
The pills are hidden inside food ranging from apples and bananas to sweets.
Unaffordable treatment for severe malaria highlights U.S. drug market pitfalls
It is shocking to think that U.S. citizens may receive better treatment for severe malaria at lower cost in a low-income country than they would…
A promising genetic treatment tailor-made for a baby born with a rare disorder
For the first time, doctors have created a customized treatment using the revolutionary gene-editing technique known as CRISPR to treat a baby with a rare,…
Why we should seriously consider vaccinating wild birds to control bird flu
Facing high egg prices, the Trump administration is considering vaccinating poultry against bird flu, but H5N1 is already out of barn. It’s infected nearly 500…
Countering Health Misinformation, By the Numbers
In this column, KFF President and CEO Drew Altman examines the threat posed by health misinformation and opportunities to combat it by relying on the…
3 measles cases confirmed in Orange County
The patients are young children who recently traveled internationally.
Nipah Virus Case Confirmed In Kerala’s Malappuram District, Woman Infected
A case of Nipah virus has been confirmed in the Malappuram district of Kerala, health officials said on Wednesday.
Trump Executive Order Restricts ‘Gain of Function’ Research on Pathogens
Scientists have long debated the merits and risks of tinkering with viruses and bacteria, which the president claims caused the coronavirus pandemic.
Uganda declares end to latest ebola outbreak
It said the declaration followed 42 days “without a new case since the last confirmed patient was discharged.”
Millions of U.S. measles cases forecast over 25 years if shots decline
Measles, once virtually wiped out in the United States, could become commonplace again if declining vaccination rates continue, a new model shows.